Episodes of paralysis in Chinese men with thyrotoxic periodic paralysis are associated with elevated serum testosterone

Thyroid

Volumn 23, Issue 4, 2013, Pages 420-427

  Yao, Yu ^a   Fan, Linbo ^b   Zhang, Xiangxun ^a   Xiao, Zhu ^a   Long, Yang ^a   Tian, Haoming ^a  

^a SICHUAN UNIVERSITY   (China)

^b School of Public Health   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; TESTOSTERONE;

ADULT; ARTICLE; CHINESE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROLYTE BLOOD LEVEL; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIODIC PARALYSIS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; THYROTOXICOSIS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; HUMANS; MALE; MIDDLE AGED; PARALYSES, FAMILIAL PERIODIC; TESTOSTERONE; THYROID FUNCTION TESTS; THYROTOXICOSIS; THYROXINE; TRIIODOTHYRONINE;

EID: 84875736438     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0493     Document Type: Article

References (39)

1. Lin SH 2005 Thyrotoxic periodic paralysis. Mayo Clin Proc 80:99-105.
2. Okinaka S, Shizume K, Iino S, Watanabe A, Irie M, Noguchi A, Kuma S, Kuma K, Ito T 1957 The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab 17:1454-1459.
3. Engel AG 1961 Thyroid function and periodic paralysis. Am J Med 30:327-333.
4. McFadzean AJ, Yeung R 1967 Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J 1:451-455.
5. Shizume K, Shishiba Y, Kuma K, Noguchi S, Tajiri J, Ito K, Noh JY 1992 Comparison of the incidence of association of periodic paralysis and hyperthyroidism in Japan in 1957 and 1991. Endocrinol Jpn 39:315-318.
6. Satoyoshi E, Murakami K, Kowa H, Kinoshita M, Nishiyama Y 1963 Periodic paralysis in hyperthyroidism. Neurology 13:746-752.
7. Kelley DE, Gharib H, Kennedy FP, Duda RJ Jr, McManis PG 1989 Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med 149:2597-2600.
8. Maciel RM, Lindsey SC, Dias da Silva MR 2011 Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. Nat Rev Endocrinol 7:657-667.
9. Vanderpump MP 2011 The epidemiology of thyroid disease. Br Med Bull 99:39-51.
10. Shizume K, Shishiba Y, Sakuma M, Yamauchi H, Nakao K, Okinaka S 1966 Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. I. Arteriovenous differences of electrolytes during induced paralysis. Metabolism 15:138-144.
11. Shizume K, Shishiba Y, Sakuma M, Yamauchi H, Nakao K, Okinaka S 1966 Studies on electrolytes metabolism in idiopathic and thyrotoxic periodic paralysis. II. Total exchangeable sodium and potassium. Metabolism 15:145-152.
12. Khan FA, Baron DN 1987 Ion flux and Na+, K+-ATPase activity of erythrocytes and leucocytes in thyroid disease. Clin Sci (Lond) 72:171-179.
13. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R 1991 In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 303:1096-1099.
14. Kjeldsen K, Norgaard A, Gotzsche CO, Thomassen A, Clausen T 1984 Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet 2:8-10.
15. Layzer RB 1982 Periodic paralysis and the sodium-otassium pump. Ann Neurol 11:547-552.
16. Harrison AP, Clausen T 1998 Thyroid hormone-induced upregulation of Na+ channels and Na(+) -K + pumps: implications for contractility. Am J Physiol 274:R864-867.
17. Lin MH, Akera T 1978 Increased (Na+, K+) -ATPase concentrations in various tissues of rats caused by thyroid hormone treatment. J Biol Chem 253:723-726.
18. Brown MJ, Brown DC, Murphy MB 1983 Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 309:1414-1419.
19. Gennari FJ 1998 Hypokalemia. N Engl J Med 339:451-458.
20. Ginsberg AM, Clutter WE, Shah SD, Cryer PE 1981 Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-Adrenergic receptor density in man. J Clin Invest 67:1785-1791.
21. Guerra M, Rodriguez del Castillo A, Battaner E, Mas M 1987 Androgens stimulate preoptic area Na+, K+-ATPase activity in male rats. Neurosci Lett 78:97-100.
22. Azzarolo AM, Mircheff AK, Kaswan RL, Stanczyk FZ, Gentschein E, Becker L, Nassir B, Warren DW 1997 Androgen support of lacrimal gland function. Endocrine 6:39-45.
23. Biering H, Bauditz J, Pirlich M, Lochs H, Gerl H 2003 Manifestation of thyrotoxic periodic paralysis in two patients with adrenal adenomas and hyperandrogenaemia. Horm Res 59:301-304.
24. Song M, Helguera G, Eghbali M, Zhu N, Zarei MM, Olcese R, Toro L, Stefani E 2001 Remodeling of Kv4.3 potassium channel gene expression under the control of sex hormones. J Biol Chem 276:31883-31890.
25. Li W, Changsheng C, Jiangfang F, Bin G, Nanyan Z, Xiaomiao L, Deqiang L, Ying X, Wensong Z, Qiuhe J 2010 Effects of sex steroid hormones, thyroid hormone levels, and insulin regulation on thyrotoxic periodic paralysis in Chinese men. Endocrine 38:386-390.
26. Tian HM, Zhou R, Yang L, Ren JL 1999 The changes of serum thyroid hormone and sex hormone levels in male TPP patients. Chinese General Practice 2:23-25.
27. Kung AW, Lau KS, Fong GC, Chan V 2004 Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 89:1340-1345.
28. Gray A, Feldman HA, McKinlay JB, Longcope C 1991 Age, disease, and changing sex hormone levels in middle-Aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73:1016-1025.
29. Chopra IJ 1975 Gonadal steroids and gonadotropins in hyperthyroidism. Med Clin North Am 59:1109-1121.
30. Tsuchiya A 1981A study of thyroid hormone influence on the gonad in hyperthyroid males. Fukushima J Med Sci 27:133-147.
31. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA 2005 Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 90:6472-6479.
32. Ford HC, Cooke RR, Keightley EA, Feek CM 1992 Serum levels of free and bound testosterone in hyperthyroidism. Clin Endocrinol 36:187-192.
33. Chopra IJ, Tulchinsky D 1974 Status of estrogen-Androgen balance in hyperthyroid men with Graves' disease. J Clin Endocrinol Metab 38:269-277.
34. Dunn JF, Nisula BC, Rodbard D 1981 Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 53:58-68.
35. Aoki N, Maruyama Y, Imamura M, Ohno Y, Saika T, Yamamoto T, Suzuki Y, Sinohara H 1986 Studies of sexsteroid- binding plasma protein (SBP) in Graves' disease before and under antithyroid drug therapy. Acta Endocrinol (Copenh) 113:249-254.
36. de Nayer P, Lambot MP, Desmons MC, Rennotte B, Malvaux P, Beckers C 1986 Sex hormone-binding protein in hyper- thyroxinemic patients: a discriminator for thyroid status in thyroid hormone resistance and familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab 62:1309-1312.
37. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H 2007 Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405-413.
38. Fritz KS, McKean AJ, Nelson JC, Wilcox RB 2008 Analogbased free testosterone test results linked to total testosterone concentrations, not free testosterone concentrations. Clin Chem 54:512-516.
39. Swerdloff RS, Wang C 2008 Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence. Clin Chem 54:458-460.